Drug Profile
Research programme: peptide therapeutics - Lee's Pharmaceutical
Alternative Names: Papain - Lee's Pharmaceutical; Thymosin beta-4 - Lee's Pharmaceutical; ZK003; ZK004; ZK005Latest Information Update: 23 Feb 2023
Price :
$50
*
At a glance
- Originator Lee's Pharmaceutical
- Class Peptides
- Mechanism of Action Angiogenesis inducing agents; Apoptosis inhibitors; Cell movement activators; Collagen stimulants; Stem cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alopecia; Eye disorders; Hypertrophic scars; Vulvovaginal candidiasis
Most Recent Events
- 23 Feb 2023 Discontinued - Preclinical for Alopecia (Chemotherapy-induced) in China (unspecified route) (Lee's Pharmaceutical pipeline, February 2023)
- 23 Feb 2023 Discontinued - Preclinical for Eye disorders in China (Ophthalmic) (Lee's Pharmaceutical pipeline, February 2023)
- 23 Feb 2023 Discontinued - Preclinical for Vulvovaginal candidiasis in China (unspecified route) (Lee's Pharmaceutical pipeline, February 2023)